Setting (ref) | Sample Size | Statin Use | ACE InhibitorUse | Beta-blockerUse | Antiplatelet Use | Current Smokers | % with cholesterol at or below target* |
---|---|---|---|---|---|---|---|
Audits from General Practices: | |||||||
Canada (42) | 4315 | 38% | NR | NR | 53% | 25% | 14% |
Canada (43) | NR | NR | NR | NR | 54% | NR | NR |
USA (46) | 11 745 | NR | NR | 21% | NR | NR | NR |
UK (41) | 1921 | NR | 10% | 32% | 63% | 18% | 17% |
UK (44) | 24 431 | 16% | 13% | 22% | 50% | 24% | 56% |
Canada (49) | 3721 | 100% | NR | NR | NR | 17% | 73% |
International REACH Registry (50) | 40 258 | 76% | 51% | 63% | 86% | 13% | NR |
Audits in patients discharged after acute myocardial infarction or coronary artery bypass surgery: | |||||||
USA (39) | 201 752 | NR | 30% | 34% | 83% | NR | NR |
USA (37) | 1710 | 12% | NR | 44% | 53% | NR | NR |
USA (38) | 622 | 37% | NR | 23% | 46% | 25% | 15% |
USA (45) | 190 015 | NR | 31% | NR | NR | NR | NR |
USA (47) | 25 000 | NR | NR | NR | 81% | NR | NR |
Europe (40) | 3379 | 58% | 43% | 66% | 84% | 21% | 41% |
Ontario(48) | 9667 | 40% | 65% | 68% | NR | NR | NR |
Quebec(48) | 4790 | 43% | 57% | 68% | NR | NR | NR |
British Columbia(48) | 2570 | 42% | 58% | 61% | NR | NR | NR |
Nova Scotia(48) | 761 | 36% | 58% | 83% | NR | NR | NR |
Alberta (APPROACH patients)** | 5104 | 34% | 39% | 61% | 81% | NR | NR |